Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Mindray Medical Reports Stellar 2009 Results

publication date: Mar 2, 2010
Mindray Medical (迈瑞医疗国际有限公司), the medical device company headquartered in Shenzhen, issued a very positive financial report for 2009. The company recorded revenues of $634 million, an increase of 16%, while net income climbed to $139.2 million, a 28% jump. For 2010, Mindray said it expects revenue growth to continue at a 17% pace; non-GAAP net income is expected to match that rate, giving evidence of the continuing vitality of the medical device sector. More details...

Stock Symbol: (NYSE: MR)


Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital